Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Genmab
GMAB
$17.7B
| $1.28M | ﹤0.01% |
61,177
+35,073
| +134% | +$771K |
|
2827
Fate Therapeutics
FATE
$286M
| $1.27M | ﹤0.01% |
770,280
+6,472
| +0.8% | +$16.3K |
|
2828
Graham Corp
GHM
$1.12B
| $1.27M | ﹤0.01% |
28,491
-774
| -3% | -$29K |
|
|
TSVT
2829
DELISTED
2seventy bio
TSVT
| $1.26M | ﹤0.01% |
428,660
+15,061
| +4% | +$61.8K |
|
2830
Zevra Therapeutics
ZVRA
$562M
| $1.25M | ﹤0.01% |
149,504
+28,148
| +23% | +$240K |
|
2831
Vodafone
VOD
$36.3B
| $1.24M | ﹤0.01% |
146,624
-10,399
| -7% | -$94.7K |
|
2832
Star Bulk Carriers
SBLK
$3.21B
| $1.23M | ﹤0.01% |
82,441
-80,662
| -49% | -$1.5M |
|
2833
Nordic American Tanker
NAT
$1.38B
| $1.22M | ﹤0.01% |
489,367
-15
| -0% | -$46 |
|
2834
NVE Corp
NVEC
$562M
| $1.22M | ﹤0.01% |
15,021
-11
| -0.1% | -$863 |
|
2835
Porch Group
PRCH
$1.64B
| $1.22M | ﹤0.01% |
248,200
+11,849
| +5% | +$38K |
|
2836
Rimini Street
RMNI
$449M
| $1.22M | ﹤0.01% |
457,181
+12,300
| +3% | +$25.1K |
|
|
ESPR
2837
DELISTED
Esperion Therapeutics
ESPR
| $1.22M | ﹤0.01% |
554,216
-698
| -0.1% | -$1.63K |
|
2838
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.38B
| $1.22M | ﹤0.01% |
93,757
-6,147,659
| -98% | -$82.9M |
|
2839
Alector
ALEC
$168M
| $1.22M | ﹤0.01% |
643,456
-117,150
| -15% | -$441K |
|
2840
Ardagh Metal Packaging
AMBP
$2.83B
| $1.22M | ﹤0.01% |
403,984
-52,143
| -11% | -$188K |
|
2841
MaxCyte
MXCT
$112M
| $1.21M | ﹤0.01% |
291,980
-7,693
| -3% | -$29.1K |
|
2842
EVgo
EVGO
$223M
| $1.21M | ﹤0.01% |
298,794
+5,377
| +2% | +$34.2K |
|
|
TEF
2843
DELISTED
Telefonica
TEF
| $1.21M | ﹤0.01% |
300,470
-7,926
| -3% | -$35.7K |
|
2844
Talkspace
TALK
$874M
| $1.2M | ﹤0.01% |
389,312
+10,835
| +3% | +$33K |
|
|
GPGI
2845
GPGI Inc
GPGI
$3.83B
| $1.19M | ﹤0.01% |
93,762
+10,491
| +13% | +$133K |
|
2846
South Plains Financial
SPFI
$845M
| $1.19M | ﹤0.01% |
34,340
+991
| +3% | +$35.9K |
|
2847
Oil-Dri
ODC
$1.44B
| $1.19M | ﹤0.01% |
27,226
-792
| -3% | -$29K |
|
2848
Northrim BanCorp
NRIM
$590M
| $1.19M | ﹤0.01% |
61,124
-1,584
| -3% | -$30.3K |
|
2849
Holley
HLLY
$321M
| $1.19M | ﹤0.01% |
393,584
-49,885
| -11% | -$140K |
|
2850
Caribou Biosciences
CRBU
$145M
| $1.19M | ﹤0.01% |
745,726
+6,196
| +0.8% | +$12.5K |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.